Atrys Health, S.A. (BME:ATRY)
Spain · Delayed Price · Currency is EUR 2.820
-0.080 (-2.76%)
At close: Mar 18, 2026
Atrys Health Market Cap
Atrys Health has a market cap or net worth of €213.97 million as of March 18, 2026. Its market cap has decreased by -13.30% in one year.
Market Cap
213.97M
Enterprise Value
450.53M
Revenue
226.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.82
Market Cap Chart
Since July 22, 2016, Atrys Health's market cap has increased from 17.85M to 213.97M, an increase of 1,099.02%. That is a compound annual growth rate of 29.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 213.97M | -3.75% |
| Dec 31, 2025 | 222.31M | -13.13% |
| Dec 31, 2024 | 255.91M | -8.07% |
| Dec 29, 2023 | 278.37M | -39.03% |
| Dec 30, 2022 | 456.55M | -26.48% |
| Dec 30, 2021 | 620.95M | 107.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.71B |
| Laboratorios Farmaceuticos Rovi | 4.09B |
| Almirall | 2.46B |
| Pharma Mar | 1.50B |
| Clínica Baviera | 804.13M |
| Oryzon Genomics | 221.69M |
| Prim, S.A. | 217.80M |
| Laboratorio Reig Jofre | 191.32M |